Lilly lung cancer drug improves survival in late-stage trial
(Reuters) - An experimental cancer drug developed by Eli Lilly and Co, touted by some to be the company's next blockbuster, significantly improved sur...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/mCdCmNkGeCc/story01.htm
No comments:
Post a Comment